{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:01:24Z","timestamp":1784588484347,"version":"3.55.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010029","name":"University of Lancaster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010029","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s12031-017-0942-9","type":"journal-article","created":{"date-parts":[[2017,7,9]],"date-time":"2017-07-09T23:17:12Z","timestamp":1499642232000},"page":"344-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Role of Apolipoproteins and \u03b1-Synuclein in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4211-6613","authenticated-orcid":false,"given":"Fatemeh Nouri","family":"Emamzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"942_CR1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ana.20780","volume":"59","author":"A Acciarri","year":"2006","unstructured":"Acciarri A, Masullo C, Bizzarro A (2006) ApoE epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia. Ann Neurol 59:436\u2013437","journal-title":"Ann Neurol"},{"key":"942_CR2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1073\/pnas.0812697106","volume":"106","author":"F Agosta","year":"2009","unstructured":"Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, Boxer AL, Karydas A, Possin KL, Gorno-Tempini ML (2009) Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer\u2019s disease and frontotemporal dementia. Proc Natl Acad Sci USA 106:2018\u20132022","journal-title":"Proc Natl Acad Sci USA"},{"key":"942_CR3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ana.24393","volume":"77","author":"A Alonso","year":"2015","unstructured":"Alonso A, Huang X, Mosley TH, Heiss G, Chen H (2015) Heart rate variability and the risk of Parkinson disease: the atherosclerosis risk in communities study. Ann Neurol 77:877\u2013883","journal-title":"Ann Neurol"},{"key":"942_CR4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42:360\u2013367","journal-title":"Neurobiol Dis"},{"key":"942_CR5","doi-asserted-by":"crossref","first-page":"24065","DOI":"10.1074\/jbc.M002413200","volume":"275","author":"C Alves da Costa","year":"2000","unstructured":"Alves da Costa C, Ancolio K, Checler F (2000) Wild-type but not Parkinson\u2019s disease-related ala-53 \u2192 Thr mutant \u03b1-synuclein protects neuronal cells from apoptotic stimuli. Biol Chem 275:24065\u201324069","journal-title":"Biol Chem"},{"key":"942_CR6","doi-asserted-by":"crossref","unstructured":"Amouyel P, Vidal O, Launay JM, Laplanche JL (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet 344: 1315\u20131318","DOI":"10.1016\/S0140-6736(94)90691-2"},{"key":"942_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuropharm.2010.01.005","volume":"59","author":"KR Bales","year":"2010","unstructured":"Bales KR (2010) Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer\u2019s disease. Neuropharmacology 59:295\u2013302","journal-title":"Neuropharmacology"},{"key":"942_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40478-015-0254-7","volume":"3","author":"ME Bernis","year":"2015","unstructured":"Bernis ME, Babila JT, Breid S, W\u00fcsten KA, W\u00fcllner U, Tamg\u00fcney G (2015) Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol Commun 3:75","journal-title":"Acta Neuropathol Commun"},{"key":"942_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2202-11-41","volume":"11","author":"M Bisaglia","year":"2010","unstructured":"Bisaglia M, Greggio E, Maric D, Miller DW, Cookson MR, Bubacco L (2010) Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells. BMC Neurosci 11:41","journal-title":"BMC Neurosci"},{"key":"942_CR10","doi-asserted-by":"crossref","unstructured":"Blair, C. K., Folsom, A. R., Knopman, D. S., Bray, M. S., Mosley, T. H., Boerwinkle, E., Atherosclerosis risk in communities (ARIC) study investigators. APOE genotype and cognitive decline in a middle-aged cohort Neurology 64: 268\u2013276, 2005.","DOI":"10.1212\/01.WNL.0000149643.91367.8A"},{"key":"942_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2006.07.037","volume":"406","author":"L Bl\u00e1zquez","year":"2006","unstructured":"Bl\u00e1zquez L, Otaegui D, S\u00e1enz A, Pais\u00e1n-Ruiz C, Emparanza JI, Ruiz-Martinez J, Moreno F, Mart\u00ed-Mass\u00f3 JF, L\u00f3pez de Munain A (2006) Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson\u2019s disease. Neurosci Lett 406:235\u2013239","journal-title":"Neurosci Lett"},{"key":"942_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"942_CR13","doi-asserted-by":"crossref","unstructured":"Braesch-Andersen S, Beckman L, Paulie S, Kumagai-Braesch M (2014) ApoD mediates binding of HDL to LDL and to growing T24 carcinoma. PLoS One 9:e115180","DOI":"10.1371\/journal.pone.0115180"},{"key":"942_CR14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0006-291X(83)91772-2","volume":"113","author":"HB Brewer Jr","year":"1983","unstructured":"Brewer HB Jr, Fairwell T, Kay L, Meng M, Ronan R, Law S, Light JA (1983) Human plasma proapoA-I: isolation and amino-terminal sequence. Biochem Biophys Res Commun 113:626\u2013632","journal-title":"Biochem Biophys Res Commun"},{"key":"942_CR15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.56.3.312","volume":"56","author":"J Chapman","year":"2001","unstructured":"Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewczyk K, Birnbaum M, Michaelson DM, Korczyn AD (2001) APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 56:312\u2013316","journal-title":"Neurology"},{"key":"942_CR16","doi-asserted-by":"crossref","first-page":"49142","DOI":"10.1074\/jbc.M104879200","volume":"276","author":"G Chen","year":"2001","unstructured":"Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S (2001) A protective role for kidney apolipoprotein E: regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 276:49142\u201349147","journal-title":"J Biol Chem"},{"key":"942_CR17","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","volume":"286","author":"H-K Chen","year":"2011","unstructured":"Chen H-K, Ji Z-S, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, Freedman SB, Weisgraber KH, Huang Y, Mahley RW (2011) Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer\u2019s disease. J Biol Chem 286:5215\u20135221","journal-title":"J Biol Chem"},{"key":"942_CR18","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1212\/WNL.57.12.2223","volume":"57","author":"RM Cohen","year":"2001","unstructured":"Cohen RM, Small C, Lalonde F, Friz J, Sunderland T (2001) Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 57:2223\u20132228","journal-title":"Neurology"},{"key":"942_CR19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00221-009-1862-x","volume":"196","author":"LS Colzato","year":"2009","unstructured":"Colzato LS, Van Den Wildenberg WP, Van Wouwe NC, Pannebakker MM, Hommel B (2009) Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Exp Brain Res 196:467\u2013474","journal-title":"Exp Brain Res"},{"key":"942_CR20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alphasynuclein adduct. Science 294:1346\u20131349","journal-title":"Science"},{"key":"942_CR21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923","journal-title":"Science"},{"key":"942_CR22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.58.7.1045","volume":"58","author":"G Dal Forno","year":"2002","unstructured":"Dal Forno G, Carson KA, Brookmeyer R, Troncoso J, Kawas CH, Brandt J (2002) APOE genotype and survival in men and women with Alzheimer\u2019s disease. Neurology 58:1045\u20131050","journal-title":"Neurology"},{"key":"942_CR23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/humu.1380040303","volume":"4","author":"P Knijff de","year":"1994","unstructured":"de Knijff P, van den Maagdenberg AMJM, Frants RR, Havekes LM (1994) Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 4:178\u2013194","journal-title":"Hum Mutat"},{"key":"942_CR24","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/bi00474a025","volume":"29","author":"HV Silva de","year":"1990","unstructured":"de Silva HV, Harmony JA, Stuart WD, Gil CM, Robbins J (1990) Apolipoprotein J: structure and tissue distribution. Biochemistry 29:5380\u20135389","journal-title":"Biochemistry"},{"key":"942_CR25","first-page":"33","volume":"69","author":"RC Duvoisin","year":"1996","unstructured":"Duvoisin RC (1996) Recent advances in the genetics of Parkinson\u2019s disease. Adv Neurol 69:33\u201340","journal-title":"Adv Neurol"},{"key":"942_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","volume":"51","author":"DA Elliott","year":"2010","unstructured":"Elliott DA, Weickert CS, Garner B (2010) Apolipoproteins in the brain: implications for neurological and psychiatric disorders. Clin Lipidol 51:555\u2013573","journal-title":"Clin Lipidol"},{"key":"942_CR27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","volume":"21","author":"FN Emamzadeh","year":"2016","unstructured":"Emamzadeh FN (2016) Alpha-synuclein structure, functions, and interactions. J Res Med Sci 21:29","journal-title":"J Res Med Sci"},{"key":"942_CR28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2016.02.042","volume":"618","author":"FN Emamzadeh","year":"2016","unstructured":"Emamzadeh FN, Aojula H, McHugh PC, Allsop D (2016) Effects of different isoforms of apoE on aggregation of the \u03b1-synuclein protein implicated in Parkinson\u2019s disease. Neurosci Lett 618:146\u2013151","journal-title":"Neurosci Lett"},{"key":"942_CR29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/jnnp.2010.222042","volume":"82","author":"SA Factor","year":"2011","unstructured":"Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H (2011) Postural instability\/gait disturbance in Parkinson\u2019s disease has distinct subtypes: an exploratory analysis. J Neurol Neurosurg Psychiatry 82:564\u2013568","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"942_CR30","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.bbamem.2011.06.017","volume":"1808","author":"J Fantini","year":"2011","unstructured":"Fantini J, Carlus D, Yahi N (2011) The fusogenic tilted peptide (67-78) of \u03b1-synuclein is a cholesterol binding domain. Biochim Biophys Acta 1808:2343\u20132351","journal-title":"Biochim Biophys Acta"},{"key":"942_CR31","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/01.WNL.0000144279.21502.B7","volume":"63","author":"MR Farlow","year":"2004","unstructured":"Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC (2004) Impact of APOE in mild cognitive impairment. Neurology 63:1898\u20131901","journal-title":"Neurology"},{"key":"942_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.nbd.2012.02.002","volume":"46","author":"M Federoff","year":"2012","unstructured":"Federoff M, Jimenez-Rolando B, Nalls MA, Singleton AB (2012) A large study reveals no association between APOE and Parkinson\u2019s disease. Neurobiol Dis 46:389\u2013392","journal-title":"Neurobiol Dis"},{"key":"942_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12264-007-0008-z","volume":"23","author":"N Gao","year":"2007","unstructured":"Gao N, Li YH, Li X, Yu S, Fu GL, Chen B (2007) Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene. Neurosci Bull 23:53\u201357","journal-title":"Neurosci Bull"},{"key":"942_CR34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/bj3310231","volume":"331","author":"IC Gelissen","year":"1998","unstructured":"Gelissen IC, Hochgrebe T, Wilson MR, Easterbrook-Smith SB, Jessup W, Dean RT, Brown AJ (1998) Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function? Biochem J 331:231\u2013237","journal-title":"Biochem J"},{"key":"942_CR35","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1093\/nar\/gni155","volume":"33","author":"N Ghebranious","year":"2005","unstructured":"Ghebranious N, Ivacic L, Mallum J, Dokken C (2005) Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology. Nucleic Acids Res 33:e149","journal-title":"Nucleic Acids Res"},{"key":"942_CR36","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/WNL.56.12.1696","volume":"56","author":"E Ghebremedhin","year":"2001","unstructured":"Ghebremedhin E, Schultz C, Thal DR, Rub U, Ohm TG, Braak E (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56:1696\u20131701","journal-title":"Neurology"},{"key":"942_CR37","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1073\/pnas.0704908104","volume":"104","author":"A Ghosh","year":"2007","unstructured":"Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 104:18754\u201318759","journal-title":"Proc Natl Acad Sci USA"},{"key":"942_CR38","doi-asserted-by":"publisher","first-page":"641515","DOI":"10.1155\/2013\/641515","volume":"2013","author":"ML Gregorio","year":"2013","unstructured":"Gregorio ML, Pinhel MA, Sado CL, Longo GS, Oliveira FN, Amorim GS, Nakazone MA, Florim GM, Mazeti CM, Martins DP, Tognola WA, Brand\u00e3o AC, J\u00fanior SP, de Godoy MF, Souza DR (2013) Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson\u2019s disease. Biomed Res Int 2013:641515. doi: 10.1155\/2013\/641515","journal-title":"Biomed Res Int"},{"key":"942_CR39","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbadis.2009.06.010","volume":"1792","author":"R Harada","year":"2009","unstructured":"Harada R, Kobayashi N, Kim J, Nakamura C, Han SW, Ikebukuro K, Sode K (2009) The effect of amino acid substitution in the imperfect repeat sequences of \u03b1-synuclein on fibrillation. Biochim Biophys 1792:998\u20131003","journal-title":"Biochim Biophys"},{"key":"942_CR40","doi-asserted-by":"crossref","unstructured":"Hayashi H, Campenot RB, Vance DE, Vance JE (2007) Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1. J Neurosci 27:1933\u20131941","DOI":"10.1523\/JNEUROSCI.5471-06.2007"},{"key":"942_CR41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133:713\u2013726","journal-title":"Brain"},{"key":"942_CR42","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1212\/01.WNL.0000130159.28215.6A","volume":"62","author":"X Huang","year":"2004","unstructured":"Huang X, Chen PC, Poole C (2004) APOE\u03b52 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 62:2198\u20132202","journal-title":"Neurology"},{"key":"942_CR43","doi-asserted-by":"crossref","first-page":"45320","DOI":"10.1074\/jbc.M103736200","volume":"276","author":"A Iwata","year":"2001","unstructured":"Iwata A (2001) Maruyama1, M., Kanazawa, I., Nukina, N. \u03b1 -Synuclein affects the MAPK pathway and accelerates cell death. Biol Chem 276:45320\u201345329","journal-title":"Biol Chem"},{"key":"942_CR44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"942_CR45","doi-asserted-by":"crossref","first-page":"26292","DOI":"10.1074\/jbc.273.41.26292","volume":"273","author":"P Jensen","year":"1998","unstructured":"Jensen P, Nielsen M, Jakes R, Dotti C, Goedert M (1998) Binding of \u03b1-synuclein to brain vesicles is abolished by familial Parkinson\u2019s disease mutation. Biol Chem 273:26292\u201326294","journal-title":"Biol Chem"},{"key":"942_CR46","first-page":"103","volume":"22","author":"K Kamino","year":"2002","unstructured":"Kamino K, Tanaka T, Kida T, Ohkochi M, Tanii H, Kudo T, Takeda M (2002) The role of lipid metabolism in Alzheimer\u2019s disease. Nihon Shinkei Seishin Yakurigaku Zasshi 22:103\u2013110","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"942_CR47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156720511795256071","volume":"8","author":"RJ Kandimalla","year":"2011","unstructured":"Kandimalla RJ, Prabhakar S, Binukumar BK, Wani WY, Gupta N, Sharma DR, Sunkaria A, Grover VK, Bhardwaj N, Jain K, Gill KD (2011) Apo-E\u03b54 allele in conjunction with A\u03b242 and tau in CSF: biomarker for Alzheimer\u2019s disease. Curr Alzheimer Res 8:187\u2013196","journal-title":"Curr Alzheimer Res"},{"key":"942_CR48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/01.WNL.0000113721.83287.83","volume":"62","author":"OH Kantarci","year":"2004","unstructured":"Kantarci OH, Hebrink DD, Achenbach SJ, Pittock SJ, Altintas A, Schaefer-Klein JL, Atkinson EJ, de Andrade M, McMurray CT, Rodriguez M, Weinshenker BG (2004) Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology 62:811\u2013814","journal-title":"Neurology"},{"key":"942_CR49","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/jnnp.57.11.1414","volume":"57","author":"J Kawamata","year":"1994","unstructured":"Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J (1994) Apolipoprotein E polymorphism in Japanese patients with Alzheimer\u2019s disease or vascular dementia. J Neurol Neurosurg Psychiatry 57:1414\u20131416","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"942_CR50","first-page":"108","volume":"36","author":"P Kehoe","year":"1999","unstructured":"Kehoe P, Krawczak M, Harper PS, Owen MJ, Jones AL (1999) Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet 36:108\u2013111","journal-title":"J Med Genet"},{"key":"942_CR51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2009.11.015","volume":"221","author":"AO Koob","year":"2010","unstructured":"Koob AO, Ubhi K, Paulsson JF, Kelly J, Rockenstein E, Mante M, Adame A, Masliah E (2010) Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Exp Neurol 221:267\u2013274","journal-title":"Exp Neurol"},{"key":"942_CR52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000254468.51973.44","volume":"68","author":"G Koutsis","year":"2007","unstructured":"Koutsis G, Panas M, Giogkaraki E et al (2007) APOE epsilon4 is associated with impaired verbal learning in patients with MS. Neurology 68:546\u2013549","journal-title":"Neurology"},{"key":"942_CR53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3940(01)01806-7","volume":"306","author":"JC Lambert","year":"2001","unstructured":"Lambert JC, Harris JM, Mann D, Lemmon H, Coates J, Cumming A, St-Clair D, Lendon C (2001) Are the estrogen receptors involved in Alzheimer\u2019s disease? Neurosci Lett 306:193\u2013197","journal-title":"Neurosci Lett"},{"key":"942_CR54","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1523\/JNEUROSCI.3821-06.2006","volume":"26","author":"KE Larsen","year":"2006","unstructured":"Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle M, Nemani V, Chaudhry FA, Edwards RH, Stefanis L, Sulzer D (2006) Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci 26:11915\u201311922","journal-title":"J Neurosci"},{"key":"942_CR55","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"A Lees","year":"2009","unstructured":"Lees A, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"key":"942_CR56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson\u2019s disease. Nature 395:451\u2013452","journal-title":"Nature"},{"key":"942_CR57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/hmg\/ddp012","volume":"18","author":"S Lesage","year":"2009","unstructured":"Lesage S, Brice A (2009) Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18:48\u201359","journal-title":"Hum Mol Genet"},{"key":"942_CR58","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"8","author":"W Li","year":"2005","unstructured":"Li W, West N, Colla E, Pletnikova O, Troncoso JC, Marsh L, Dawson TM, J\u00e4k\u00e4l\u00e4 P, Hartmann T, Price DL, Lee MK (2005) Aggregation promoting C-terminal truncation of \u03b1-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc Natl Acad Sci USA 8:2162\u20132167","journal-title":"Proc Natl Acad Sci USA"},{"key":"942_CR59","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, Jensen PH (2004) Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279:12924\u201312934","journal-title":"J Biol Chem"},{"key":"942_CR60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2012","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G (2012) Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy. Nat Rev Neurol 9:106\u2013118","journal-title":"Nat Rev Neurol"},{"key":"942_CR61","doi-asserted-by":"crossref","first-page":"38884","DOI":"10.1074\/jbc.M205518200","volume":"277","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P (2002) Effect of mutant \u03b1-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277:38884\u201338894","journal-title":"J Biol Chem"},{"key":"942_CR62","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1074\/jbc.M110.100867","volume":"285","author":"HMSE Lou","year":"2010","unstructured":"Lou HMSE, Alerte TN, Wang J, Wu J, Peng XM, Hong CS, Friedrich EE, Mader SA, Pedersen CJ, Marcus BS, McCormack AL, Di Monte DA, Daubner SC, Perez RG (2010) Serine 129 phosphorylation reduces \u03b1\u2013synuclein\u2019s ability to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo. J Biol Chem 285:17648\u201311766","journal-title":"J Biol Chem"},{"key":"942_CR63","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ana.410360429","volume":"36","author":"G Lucotte","year":"1994","unstructured":"Lucotte G, Turpin JC, Landais P (1994) Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer\u2019s disease. Ann Neurol 36:681\u2013682","journal-title":"Ann Neurol"},{"key":"942_CR64","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","volume":"16","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Pathological \u03b1-Synuclein transmission initiates Parkinson-like neurodegeneration in non-transgenic mice. Science 16:949\u2013953","journal-title":"Science"},{"key":"942_CR65","doi-asserted-by":"publisher","first-page":"9832839","DOI":"10.1155\/2016\/9832839","volume":"2016","author":"F Magrinelli","year":"2016","unstructured":"Magrinelli F, Picelli A, Tocco P, Federico A, Roncari L, Smania N, Zanette G, Tamburin S (2016) Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation. Parkinsons Dis 2016:9832839. doi: 10.1155\/2016\/9832839","journal-title":"Parkinsons Dis"},{"key":"942_CR66","doi-asserted-by":"crossref","first-page":"17379","DOI":"10.1074\/jbc.M209020200","volume":"278","author":"J Martinez","year":"2003","unstructured":"Martinez J, Moeller I, Erdjument-Bromage H, Tempst P, Lauring B (2003) Parkinson\u2019s disease associated \u03b1 synuclein is a calmodulin substrate. Biol Chem 278:17379\u201317387","journal-title":"Biol Chem"},{"key":"942_CR67","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1074\/jbc.275.12.8812","volume":"275","author":"PJ McLean","year":"2000","unstructured":"McLean PJ, Kawamata H, Ribich S, Hyman BT (2000) Membrane association and protein conformation of \u03b1-synuclein in intact neurons. Effect of Parkinson\u2019s disease-linked mutations. Biol Chem 275:8812\u20138816","journal-title":"Biol Chem"},{"key":"942_CR68","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/bpa.12392","volume":"27","author":"JS Miners","year":"2017","unstructured":"Miners JS, Clarke P, Love S (2017) Clusterin levels are increased in Alzheimer\u2019s disease and influence the regional distribution of A\u03b2. Brain Pathol 27:305\u2013313","journal-title":"Brain Pathol"},{"key":"942_CR69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67:122\u2013131","journal-title":"Ann Neurol"},{"key":"942_CR70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neulet.2004.09.004","volume":"371","author":"CE Moussa","year":"2004","unstructured":"Moussa CE, Wersinger C, Rusnak M, Tomita Y, Sidhu A (2004) Abnormal migration of human wild-type \u03b1-synuclein upon gel electrophoresis. Neurosci Lett 371:239\u2013243","journal-title":"Neurosci Lett"},{"key":"942_CR71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13760-013-0223-5","volume":"114","author":"M Multhammer","year":"2014","unstructured":"Multhammer M, Michels A, Zintl M, Mendoza MC, Kl\u00fcnemann HH (2014) A large ApoE \u03b54\/\u03b54 homozygous cohort reveals no association with Parkinson\u2019s disease. Acta Neurol Belg 114:25\u201331","journal-title":"Acta Neurol Belg"},{"key":"942_CR72","doi-asserted-by":"publisher","first-page":"e 77852","DOI":"10.1371\/journal.pone.0077852","volume":"8","author":"A Navarro","year":"2013","unstructured":"Navarro A, Mendez E, Diaz C, del Valle E, Martinez-Pinilla E, Ordonez C, Tolivia J (2013) Lifelong expression of apolipoprotein D in the human brainstem: correlation with reduced age-related neurodegeneration. PLoS One 8:e 77852. doi: 10.1371\/journal.pone.0077852","journal-title":"PLoS One"},{"key":"942_CR73","first-page":"361","volume":"21","author":"C Ordo\u00f1ez","year":"2006","unstructured":"Ordo\u00f1ez C, Navarro A, Perez C, Astudillo A, Mart\u00ednez E, Tolivia J (2006) Apolipoprotein D expression in substantia nigra of Parkinson disease. Histol Histopathol 21:361\u2013366","journal-title":"Histol Histopathol"},{"key":"942_CR74","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000","volume":"20","author":"N Ostrerova-Golts","year":"2000","unstructured":"Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B (2000) The A53T \u03b1 -Synuclein mutation increases iron-dependent aggregation and toxicity. Neuroscience 20:6048\u20136054","journal-title":"Neuroscience"},{"key":"942_CR75","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1006\/geno.2002.6707","volume":"79","author":"A Parsian","year":"2002","unstructured":"Parsian A, Racette B, Goldsmith LJ, Perlmutter JS (2002) Parkinson\u2019s disease and apolipoprotein E: possible association with dementia but not age at onset. Genomics 79:458\u20134561","journal-title":"Genomics"},{"key":"942_CR76","first-page":"803","volume":"58","author":"H Payami","year":"1996","unstructured":"Payami H, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, Bird TD, Yu CE, Wijsman EM, Heston LL, Litt M, Schellenberg GD (1996) Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 58:803\u2013811","journal-title":"Am J Hum Genet"},{"key":"942_CR77","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","volume":"118","author":"X Peng","year":"2005","unstructured":"Peng X, Tehranian R, Dietrich P, Stefanis L, Perez RG (2005) Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J Cell Sci 118:3523\u20133530","journal-title":"J Cell Sci"},{"key":"942_CR78","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","volume":"22","author":"RG Perez","year":"2002","unstructured":"Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090\u20133099","journal-title":"J Neurosci"},{"key":"942_CR79","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"M Phillips","year":"2014","unstructured":"Phillips M, Apolipoprotein C (2014) E isoforms and lipoprotein metabolism. IUBMB Life 66:616\u2013623","journal-title":"IUBMB Life"},{"key":"942_CR80","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.ejhg.5201447","volume":"13","author":"M Pirskanen","year":"2005","unstructured":"Pirskanen M, Hiltunen M, Mannermaa A, Helisalmi S, Lehtovirta M, H\u00e4nninen T, Soininen H (2005) Eur J Hum Genet 13:1000\u20131006","journal-title":"Eur J Hum Genet"},{"key":"942_CR81","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","volume":"333","author":"T Polvikoski","year":"1995","unstructured":"Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K (1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 333:1242\u20131247","journal-title":"N Engl J Med"},{"key":"942_CR82","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1089\/neu.2010.1623","volume":"28","author":"J Ponsford","year":"2011","unstructured":"Ponsford J, McLaren A, Sch\u00f6nberger M, Burke R, Rudzki D, Olver J, Ponsford M (2011) The association between apolipoprotein E and traumatic brain injury severity and functional outcome in a rehabilitation sample. J Neurotrauma 28:1683\u20131692","journal-title":"J Neurotrauma"},{"key":"942_CR83","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer\u2019s disease: the cholesterol connection. Nat Neurosci 6:345\u2013351","journal-title":"Nat Neurosci"},{"key":"942_CR84","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.23872","volume":"74","author":"JK Qiang","year":"2013","unstructured":"Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout DB, Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, Chen-Plotkin AS (2013) Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Ann Neurol 74:119\u2013127","journal-title":"Ann Neurol"},{"key":"942_CR85","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tins.2014.03.001","volume":"37","author":"DA Raichlen","year":"2014","unstructured":"Raichlen DA, Alexander GE (2014) Exercise, APOE genotype, and the evolution of the human lifespan. Trends Neurosci 37:247\u2013255","journal-title":"Trends Neurosci"},{"key":"942_CR86","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0047-6374(01)00283-4","volume":"122","author":"S Rajagopalan","year":"2001","unstructured":"Rajagopalan S, Andersen JK (2001) \u0391 synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson\u2019s disease? Mech Ageing Dev 122:1499\u20131510","journal-title":"Mech Ageing Dev"},{"key":"942_CR87","doi-asserted-by":"crossref","unstructured":"Rassart E, Bediriana A, Do Carmoa S, Guinarda O, Siroisa J, Terrissea L, Milneb R Apolipoprotein D (2000) Biochim Biophys Acta 1482: 185\u2013198","DOI":"10.1016\/S0167-4838(00)00162-X"},{"key":"942_CR88","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/00001756-199412000-00044","volume":"5","author":"MC Royston","year":"1994","unstructured":"Royston MC, Mann D, Pickering-Brown S, Owen F, Perry R, Raghavan R, Khin-Nu C, Tyrer S, Day K, Crook R (1994) Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down\u2019s syndrome from dementia. Neuroreport 5:2583\u20132585","journal-title":"Neuroreport"},{"key":"942_CR89","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","volume":"49","author":"V Ruip\u00e9rez","year":"2010","unstructured":"Ruip\u00e9rez V, Darios F, Davletov B (2010) Alpha-synuclein, lipids and Parkinson\u2019s disease. Prog Lipid Res 49:420\u2013428","journal-title":"Prog Lipid Res"},{"key":"942_CR90","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4314\/njm.v19i2.56496","volume":"19","author":"FK Salawu","year":"2010","unstructured":"Salawu FK, Danburam A, Olokoba AB (2010) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Niger J Med 19:126\u2013131","journal-title":"Niger J Med"},{"key":"942_CR91","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI117407","volume":"94","author":"DA Sanan","year":"1994","unstructured":"Sanan DA, Weisgraber KH, Russel SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewksi T, Frangione B, Roses B (1994) Apolipoprotein E associates with \u03b2 amyloid peptide of Alzheimer\u2019s disease to form novel monofibrils. J Clin Invest 94:860\u2013869","journal-title":"J Clin Invest"},{"key":"942_CR92","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-002-0532-x","volume":"104","author":"K Sasaki","year":"2002","unstructured":"Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T (2002) Clusterin\/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Acta Neuropathol 104:225\u2013230","journal-title":"Acta Neuropathol"},{"key":"942_CR93","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/jmg.32.6.411","volume":"32","author":"AH Schapira","year":"1995","unstructured":"Schapira AH (1995) Nuclear and mitochondrial genetics in Parkinson\u2019s disease. Med Genet 32:411\u2013414","journal-title":"Med Genet"},{"key":"942_CR94","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","volume":"103","author":"CW Shults","year":"2006","unstructured":"Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103:1661\u20131668","journal-title":"Proc Natl Acad Sci USA"},{"key":"942_CR95","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/gim.2013.12","volume":"15","author":"F Silva","year":"2013","unstructured":"Silva F, Rodriguez-Revenga L, Madrigal I, Alvarez-Mora MI, Oliva R, Mila M (2013) High apolipoprotein E4 allele frequency in FXTAS patients. Genet Med 15:639\u2013642","journal-title":"Genet Med"},{"key":"942_CR96","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1091\/mbc.E08-03-0302","volume":"20","author":"VL Sousa","year":"2009","unstructured":"Sousa VL, Bellani S, Giannandrea M, Yousuf M, Valtorta F, Meldolesi J, Chieregatti E (2009) \u03b1-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics. Mol Biol Cell 20:3725\u20133739","journal-title":"Mol Biol Cell"},{"key":"942_CR97","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","volume":"21","author":"L Stefanis","year":"2001","unstructured":"Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21:9549\u20139560","journal-title":"J Neurosci"},{"key":"942_CR98","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/cdd.2011.53","volume":"18","author":"JA Steiner","year":"2011","unstructured":"Steiner JA, Angot E, Brundin P (2011) A deadly spread: cellular mechanisms of \u03b1-synuclein transfer. Cell Death Differ 18:1425\u20131433","journal-title":"Cell Death Differ"},{"key":"942_CR99","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098\u20138102","journal-title":"Proc Natl Acad Sci USA"},{"key":"942_CR100","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.26290","volume":"30","author":"CR Swanson","year":"2015","unstructured":"Swanson CR, Berlyand Y, Xie SX, Alcalay RN, Chahine LM, Chen-Plotkin AS (2015) Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson\u2019s disease patients. Mov Disord 30:1648\u20131656","journal-title":"Mov Disord"},{"key":"942_CR101","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","volume":"9","author":"S Tabrizi","year":"2000","unstructured":"Tabrizi S, Orth M, Wilkinson JM, Taanman JW, Warner TT, Cooper JM, Schapira AHV (2000) Expression of mutant \u03b1-synuclein causes increased susceptibility to dopamine toxicity. Hum Mol Genet 9:2683\u20132689","journal-title":"Hum Mol Genet"},{"key":"942_CR102","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(94)92557-7","volume":"343","author":"C Talbot","year":"1994","unstructured":"Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A (1994) Protection against Alzheimer\u2019s disease with apoE\u03b52. Lancet 343:1432\u20131433","journal-title":"Lancet"},{"key":"942_CR103","first-page":"1122","volume":"15","author":"Y Tamam","year":"2011","unstructured":"Tamam Y, Tasdemir N, Yalman M, Tamam B (2011) Association of apolipoprotein E genotypes with prognosis in multiple sclerosis. Eur Rev Med Pharmacol Sci 15:1122\u20131130","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"942_CR104","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1749-6632.1996.tb32593.x","volume":"802","author":"MX Tang","year":"1996","unstructured":"Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R (1996) Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer\u2019s disease. Ann NY Acad Sci 802:6\u201315","journal-title":"Ann NY Acad Sci"},{"key":"942_CR105","doi-asserted-by":"crossref","first-page":"18303","DOI":"10.1073\/pnas.1314145110","volume":"110","author":"V Theendakara","year":"2013","unstructured":"Theendakara V, Patent A, Peters Libeu CA, Philpot B, Flores S, Descamps O, Poksay KS, Zhang Q, Cailing G, Hart M, John V, Rao RV, Bredesen DE (2013) Neuroprotective sirtuin ratio reversed by ApoE4. Proc Natl Acad Sci 110:18303\u201318308","journal-title":"Proc Natl Acad Sci"},{"key":"942_CR106","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62:1984\u20131989","journal-title":"Neurology"},{"key":"942_CR107","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP (2013) APOE \u03b54 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223\u2013228","journal-title":"JAMA Neurol"},{"key":"942_CR108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1460-9568.2010.07284.x","volume":"32","author":"A Ulusoy","year":"2012","unstructured":"Ulusoy A, Febbraro F, Jensen PH, Kirik D, Romero-Ramos M (2012) Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology. Eur J Neurosci 32:409\u2013422","journal-title":"Eur J Neurosci"},{"key":"942_CR109","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.nrl.0000131146.08278.a5","volume":"10","author":"AD Laar Van","year":"2004","unstructured":"Van Laar AD, Jain S (2004) Non-motor symptoms of Parkinson disease: update on the diagnosis and treatment. Neurologist 10:185\u2013194","journal-title":"Neurologist"},{"key":"942_CR110","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.febslet.2015.08.013","volume":"589","author":"A Maarschalkerweerd van","year":"2015","unstructured":"van Maarschalkerweerd A, Vetri V, Vestergaard B (2015) Cholesterol facilitates interactions between \u03b1-synuclein oligomers and charge-neutral membranes. FEBS Lett 589:2661\u20132667","journal-title":"FEBS Lett"},{"key":"942_CR111","doi-asserted-by":"crossref","first-page":"32486","DOI":"10.1074\/jbc.M110.139576","volume":"285","author":"J Varkey","year":"2010","unstructured":"Varkey J, Isas JM, Mizuno N, Jensen MB, Bhatia VK, Jao CC, Petrlova J, Voss JC, Stamou DG, Steven AC, Langen R (2010) Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J Biol Chem 285:32486\u201332493","journal-title":"J Biol Chem"},{"key":"942_CR112","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","volume":"33","author":"LL Venda","year":"2010","unstructured":"Venda LL, Cragg SJ, Buchman VL, Wade-Martins R (2010) \u03b1-Synuclein and dopamine at the crossroads of Parkinson\u2019s disease. Trends Neurosci 33:559\u2013568","journal-title":"Trends Neurosci"},{"key":"942_CR113","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cvr\/cvu148","volume":"103","author":"C Vitali","year":"2014","unstructured":"Vitali C, Wellington CL, Calabresi L (2014) HDL and cholesterol handling in the brain. Cardiovasc Res 103:405\u2013413","journal-title":"Cardiovasc Res"},{"key":"942_CR114","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283:23542\u201323556","journal-title":"J Biol Chem"},{"key":"942_CR115","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.54.11.2061","volume":"54","author":"PN Wang","year":"2000","unstructured":"Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, Yu HY, Wang SJ, Liu HC (2000) Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54:2061\u20132066","journal-title":"Neurology"},{"key":"942_CR116","first-page":"350","volume":"122","author":"ES Wang","year":"2010","unstructured":"Wang ES, Sun Y, Guo JG, Gao X, Hu JW, Zhou L, Hu J, Jiang CC (2010) Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease. Acta Neurol Scand 122:350\u2013359","journal-title":"Acta Neurol Scand"},{"key":"942_CR117","doi-asserted-by":"crossref","unstructured":"Wider C, Ross OA, Nishioka K, Heckman MG, Vilari\u00f1o-G\u00fcell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, Dickson DW (2012) An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer\u2019s and Lewy body pathology. J Neurol Neurosurg Psychiatry 83:424\u2013429","DOI":"10.1136\/jnnp-2011-301413"},{"key":"942_CR118","doi-asserted-by":"crossref","unstructured":"Wilhelmus MM, Bol JG, Van Haastert ES, Rozemuller AJ, Bu G, Drukarch B, Hoozemans JJ (2011) Apolipoprotein E and LRP1 Increase Early in Parkinson\u2019s Disease Pathogenesis. Am J Pathol 179:2152\u20132156","DOI":"10.1016\/j.ajpath.2011.07.021"},{"key":"942_CR119","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jama.287.6.742","volume":"287","author":"RS Wilson","year":"2002","unstructured":"Wilson RS, Mendes De Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA (2002) Participation in cognitively stimulating activities and risk of incident Alzheimer disease. J Am Med Assoc 287:742\u2013748","journal-title":"J Am Med Assoc"},{"key":"942_CR120","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1432-1033.1994.tb18807.x","volume":"221","author":"P Wong","year":"1994","unstructured":"Wong P, Taillefer D, Lakins J, Pineault J, Chader G, Tenniswood M (1994) Molecular characterization of human TRPM-2\/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur J Biochem 221:917\u2013925","journal-title":"Eur J Biochem"},{"key":"942_CR121","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.nbd.2005.03.010","volume":"20","author":"L Yavich","year":"2005","unstructured":"Yavich L, Oksman M, Tanila H, Kerokoski P, Hiltunen M, van Groen T, Puoliv\u00e4li J, M\u00e4nnist\u00f6 PT, Garc\u00eda-Horsman A, MacDonald E, Beyreuther K, Hartmann T, J\u00e4k\u00e4l\u00e4 P (2005) Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein. Neurobiol Dis 20:303\u2013313","journal-title":"Neurobiol Dis"},{"key":"942_CR122","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12974-015-0412-7","volume":"12","author":"LM Yshii","year":"2015","unstructured":"Yshii LM, Denadai-Souza A, Vasconcelos AR, Avellar MC, Scavone C (2015) Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells. J Neuroinflammation 12:193","journal-title":"J Neuroinflammation"},{"key":"942_CR123","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuroscience.2006.12.028","volume":"145","author":"S Yu","year":"2007","unstructured":"Yu S, Li X, Liu G, Han J, Zhang C, Li Y, Xu S, Liu C, Gao Y, Yang H, U\u00e9da K, Chan P (2007) Extensive nuclear localization of \u03b1-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145:539\u2013555","journal-title":"Neuroscience"},{"key":"942_CR124","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajmg.10111","volume":"107","author":"S Zareparsi","year":"2002","unstructured":"Zareparsi S, Camicioli R, Sexton G, Bird T, Swanson P, Kaye J, Nutt J, Payami H (2002) Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 107:156\u2013161","journal-title":"Am J Med Genet"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-017-0942-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-017-0942-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-017-0942-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T02:25:28Z","timestamp":1569723928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-017-0942-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":124,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["942"],"URL":"https:\/\/doi.org\/10.1007\/s12031-017-0942-9","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}